NCT04023201 (NQPDSH) is a clinical trial of Nocturnal symptoms in Parkinson's Disease, sponsored by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.

Who is sponsoring NCT04023201?

NCT04023201 is sponsored by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.

What drugs are being tested in NCT04023201?

Interventions in NCT04023201: Nocturnal symptoms.

What condition does NCT04023201 study?

NCT04023201 studies Parkinson's Disease.

Is NCT04023201 still recruiting?

NCT04023201 is currently status unknown. Last updated 17 July 2019.

Last reviewed 2019-07-17 · How we verify

NCT04023201: NQPDSH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai

Status unknown Last updated 17 July 2019

What this trial tests

trial testing Nocturnal symptoms in Parkinson's Disease in 1,500 participants. Status unknown.

Timeline

3 July 2019

Primary endpoint
31 December 2019

31 January 2020

Quick facts

Lead sponsor	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,500
Start date	3 July 2019
Primary completion	31 December 2019
Estimated completion	31 January 2020
Sites	1 location across China

Drugs / interventions tested

Nocturnal symptoms

Conditions studied

Parkinson's Disease — all drugs for Parkinson's Disease →

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Who can join

Eligibility, any sex, with Parkinson's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cross-sectional, retrospective clinical observation study focusing on the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Multiple comorbid sleep disorders adversely affect quality of life in Parkinson's disease patients.
Zhang Y, Zhao JH, Huang DY, Chen W, et al · · 2020 · cited 31× · PMID 33015354 · DOI 10.1038/s41531-020-00126-x

Verify or expand the search:

Other recruiting trials for Parkinson's Disease

Currently open trials in the same condition.

NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07330258 — A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite · recruiting
NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07384442 — Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's · NA · recruiting
NCT06562569 — Non-invasive VNS for PD Gait · NA · recruiting

Other Xinhua Hospital, Shanghai Jiao Tong University School of Medicine trials

Trials by the same sponsor.

NCT07506811 — Effects of Different Music Tempos on Feeding Outcomes in Preterm Infants · NA · not yet recruiting
NCT07441187 — Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type · not yet recruiting
NCT07375602 — A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children · recruiting
NCT07405658 — Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Ear · not yet recruiting
NCT07381400 — Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Stu · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04023201 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Last refreshed: 17 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04023201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing